| 91 |
Expression of Estrogen receptor beta in Squamous cell carcinoma of bladder cancer |
2020 |
| 92 |
Expression of Estrogen receptor beta in Squamous cell carcinoma of bladder cancer |
2020 |
| 93 |
Is survival with Conservative Breast Therapy becoming Superior to that with Modified Radical Mastectomy alone for the Treatment of Early Breast Cancer in this Era? |
2020 |
| 94 |
Is survival with Conservative Breast Therapy becoming Superior to that with Modified Radical Mastectomy alone for the Treatment of Early Breast Cancer in this Era? |
2020 |
| 95 |
Is survival with Conservative Breast Therapy becoming Superior to that with Modified Radical Mastectomy alone for the Treatment of Early Breast Cancer in this Era? |
2020 |
| 96 |
Is survival with Conservative Breast Therapy becoming Superior to that with Modified Radical Mastectomy alone for the Treatment of Early Breast Cancer in this Era? |
2020 |
| 97 |
Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center |
2020 |
| 98 |
Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center |
2020 |
| 99 |
Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center |
2020 |
| 100 |
Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer |
2020 |
